AFT Pharmaceuticals Ltd (ASX: AFP) Share Price and News

Price

$2.39

Movement

0.00 (0.0)

As at 22 Aug - Closed (20 mins delayed)

52 Week Range

$2.15 - $3.16

 
1 Year Return

-16.72%

AFT Pharmaceuticals Ltd Chart and Price Data

$2.25
$2.50
$2.75
$2.25
$2.50
$2.75
$2.25
$2.50
$2.75
$2.25
$2.50
$2.75

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $250.63 million
P/E Ratio 24.47
Dividend Yield 0.45%
Shares Outstanding 104.87 million
Earnings per share 0.110
Dividend per share 0.01
Year To Date Return -3.49%
Earnings Yield 4.09%
Franking -
Earnings Yield

4.09%

Franking

-

Dividend per share

0.01

Year To Date Return

-3.49%

Shares Outstanding

104.87 million

Earnings per share

0.110

Share Price

$2.39

Day Change

0.00 (0.0)

52 Week Range

$2.15 - $3.16

Yesterday's Close

$2.39

Today's Open

Days Range

-

Volume

0

Avg. Volume (1 month)

1,352

Turnover

$0

As at 22 Aug - Closed

  • AFT Pharmaceuticals Ltd (ASX: AFP)
    Latest News

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Healthcare Shares

    75% upside: Broker tips two ASX healthcare shares

    This broker sees big potential in these two Australian healthcare companies 

    Read more »

    A doctor looks unsure.
    Healthcare Shares

    What's with the AFT Pharmaceuticals (ASX:AFP) share price today?

    The AFT Pharmaceuticals (ASX: AFP) share price is still in the starting blocks this morning after the company released a…

    Read more »

    A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
    Healthcare Shares

    Why the AFT Pharmaceuticals (ASX:AFP) share price is in focus

    The AFT Pharmaceuticals (ASX: AFP) share price is one to watch today after the company signed a new US licensing…

    Read more »

    Share Market News

    Why the AFP Pharmaceuticals (ASX:AFP) share price is marching higher

    The AFP Pharmaceuticals Ltd (ASX: AFP) share price is up 3.2% today after announcing a raft of agreements and a…

    Read more »

    a woman
    Coronavirus News

    Coronavirus: ASX pharmacy networks report surge in demand

    Australian pharmacies are looking to follow in the footsteps of supermarkets, with panic-buying due to the coronavirus crisis causing a…

    Read more »

    a woman
    Coronavirus News

    Are ASX pharmaceutical shares a bargain buy right now?

    Given the recent surge in demand, ASX pharmaceutical companies could follow the supermarkets and lock in record sales figures. So,…

    Read more »

    a woman
    Share Gainers

    Why the AFT Pharmaceuticals share price is up 55% since April

    The AFT Pharmaceuticals Ltd (ASX: AFP) share price is up 55% since April 23 and closed out Friday at a…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    19 Jun 2024 $0.0098 0.00% Final 04 Jul 2024
    16 Jun 2023 $0.0069 0.00% Final 04 Jul 2023

    AFP ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    4th Aug 2025 2025-08-04T12:44:22 Results of 2025 Annual Shareholder MeetingYesNo12:44pm1149k
    1st Aug 2025 2025-08-01T07:30:51 AFT ASM PresentationYesNo7:30am304.3M
    1st Aug 2025 2025-08-01T07:30:41 AFT ASM Chairs SpeechYesNo7:30am481k
    1st Aug 2025 2025-08-01T07:30:26 AFT ASM ReleaseYesNo7:30am2119k
    4th Jul 2025 2025-07-04T07:30:27 Disclosure of Directors and Senior Managers Relevant InteresYesNo7:30am2528k
    1st Jul 2025 2025-07-01T07:31:05 June Quarter FY 2026 Investor UpdateYesNo7:31am4173k
    27th Jun 2025 2025-06-27T07:31:06 Disclosure of Directors and Senior Managers Relevant InteresYesNo7:31am2502k
    27th Jun 2025 2025-06-27T07:30:56 Notice of Annual Meeting of Shareholders 2025YesNo7:30am3162k
    24th Jun 2025 2025-06-24T15:04:31 Update - Dividend/Distribution - AFPYesNo3:04pm414k
    24th Jun 2025 2025-06-24T10:00:09 Update - Dividend/Distribution - AFPYesNo10:00am414k

    About AFT Pharmaceuticals Ltd

    AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.

    AFP Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    21 Aug 2025 $2.39 $-0.06 -2.45% 700 $2.40 $2.40 $2.39
    19 Aug 2025 $2.45 $0.00 0.00% 1,350 $2.45 $2.45 $2.45
    18 Aug 2025 $2.45 $0.06 2.51% 373 $2.45 $2.45 $2.45
    15 Aug 2025 $2.39 $0.04 1.70% 708 $2.35 $2.39 $2.35
    14 Aug 2025 $2.35 $-0.10 -4.08% 3,161 $2.45 $2.45 $2.35
    13 Aug 2025 $2.45 $0.00 0.00% 2,500 $2.45 $2.45 $2.45
    12 Aug 2025 $2.45 $0.00 0.00% 476 $2.44 $2.45 $2.44
    11 Aug 2025 $2.45 $0.05 2.08% 551 $2.45 $2.45 $2.45
    08 Aug 2025 $2.40 $-0.11 -4.38% 1,805 $2.41 $2.41 $2.40
    07 Aug 2025 $2.51 $0.06 2.45% 1,260 $2.52 $2.52 $2.51
    06 Aug 2025 $2.45 $0.05 2.08% 4,000 $2.45 $2.45 $2.45
    31 Jul 2025 $2.40 $-0.09 -3.61% 2,881 $2.49 $2.49 $2.40
    30 Jul 2025 $2.49 $-0.07 -2.73% 622 $2.57 $2.57 $2.49
    29 Jul 2025 $2.56 $-0.03 -1.16% 4,143 $2.60 $2.61 $2.50
    28 Jul 2025 $2.59 $0.11 4.44% 2,379 $2.50 $2.59 $2.50
    25 Jul 2025 $2.48 $0.02 0.81% 460 $2.48 $2.48 $2.48
    24 Jul 2025 $2.46 $-0.07 -2.77% 1,250 $2.46 $2.46 $2.46
    23 Jul 2025 $2.53 $-0.01 -0.39% 2,187 $2.53 $2.54 $2.53
    22 Jul 2025 $2.54 $0.09 3.67% 299 $2.50 $2.54 $2.50

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Nov 2024 Hartley Atkinson Buy 45 $126
    On-market trade. NZD$, As per announcement on 02-12-2024

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Andrew Michael Lane Non-Executive Director Sep 2023
    Mr Lane has more than 30 years of experience of leadership in the global pharmaceuticals industry with expertise across a broad range of disciplines including finance, manufacturing, sales, marketing, and strategy. Most recently he was Global President of Abbott Laboratories Pharma Division where he led a multi-billion-dollar operation that had 30 manufacturing plants, 12 Innovation and Development sites and 40,000 staff covering more than 100 countries. Before that he was Vice President of Takeda, Asia Pacific, where he managed the company's operations in 12 countries, which included three factories and 2,000 staff. He has also held senior roles with multi-national pharmaceutical companies Nycomed, DKSH, Novartis, and Sandoz.
    Mr David Mark Flacks Non-Executive ChairmanNon-Executive Director Jun 2015
    Mr Flacks has several governance roles and has been chair of AFT since the IPO in 2015. David is also chair of the Suncorp New Zealand group of companies and is a Director of Todd Corporation and several environmentally focused pro bono organizations. He is a director of boutique corporate law firm Flacks & Wong. David was for many years a Senior Corporate Partner at Bell Gully and was General Counsel and Company Secretary of Carter Holt Harvey during the 1990's.
    Ms Marree Atkinson Chief of Staff Co-founderManaging Director Sep 2012
    Ms Atkinson's role as Chief of Staff sees her involved in the day-to-today running of AFT's head office including managing staffing requirements and special projects involving AFT's head and affiliate offices.
    Mr Hartley Atkinson FounderChief Executive OfficerExecutive Director Sep 1997
    Mr Atkinson before founding AFT, Hartley worked at Swiss multinational pharmaceutical company, Roche, for eight years where he held positions as Sales & Marketing Director, Medical Director, Product Manager and Medical Manager. Prior to his work at Roche, Hartley was a Drug Information Pharmacist and Researcher at the Department of Clinical Pharmacology, Christchurch Hospital. Hartley is the author of several scientific publications, and his work has been published in the New England Journal of Medicine.
    Dr Ted Witek Non-Executive Director Jan 2021
    Mr Witek served Boehringer Ingelheim Pharmaceuticals for nearly 25 years in clinical research and leadership roles, including CEO of its Canadian and Portuguese operations. Ted was also Chief Scientific Officer & Senior Vice President, Corporate Partnerships, at Innoviva and on the Board of Directors of Canada's Research-Based Pharmaceutical Companies.
    Ms Allison Yorston Non-Executive Director Nov 2024
    Ms Yorston brings to AFT more than 20 years of blue-chip fast-moving consumer goods, telecommunications and retail marketing experience gained across Australia and New Zealand at senior management and C-suite levels. She has managed brand turnarounds and grown and developed marketing teams to deliver share gains in competitive markets and is experienced at managing multi-brand portfolios including both product and corporate brands. She is currently Director of Marketing at Griffins Snacks and is a former Director of the Australian Beverages Council and a former Chief Marketing Officer at Suntory Beverage & Food Oceania. Prior to Suntory she held senior marketing roles at Vodafone, Fonterra and Sanitarium.
    Mr Malcolm Tubby Chief Financial OfficerCompany Secretary
    -
    Malcolm Tubby Chief Financial OfficerCompany Secretary
    -
    Ioana Stanescu Chief Scientific Officer
    -
    Louise Clayton Director International Business
    -
    Scott Crawford General Manager Promoted Products
    -
    Murray Keith Group Marketing Manager
    -
    Vladimir Ilievski Regulatory Affairs Manager
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hartley Atkinson & Colin Mckay 72,041,741 68.70%
    Accident Compensation Corporation NZCSD 7,498,335 7.15%
    Forsyth Barr Custodians Limited 5,315,534 5.07%
    HSBC Nominees A/C NZ Superannuation Fund Nominees Limited - NZCSD 1,688,572 1.61%
    BNP Paribas Nominees (NZ) Limited NZCSD 1,096,790 1.05%
    BNP Paribas Nominees (NZ) Limited NZCSD i 1,046,390 1.00%
    New Zealand Depository Nominee Limited 877,928 0.84%
    Hama Holdings Limited1 867,826 0.83%
    MMC Queen Street Nominees Limited Acf Salt Long Short Fund NZCSD 768,123 0.73%
    Forsyth Barr Custodians Limited i 506,409 0.48%
    FNZ Custodians Limited 495,601 0.47%
    MMC Limited NZCSD 420,554 0.40%
    Custodial Services Limited 362,369 0.35%
    Garrett Smythe Limited 336,612 0.32%
    JP Morgan Nominees Australia Limited 300,000 0.29%
    Joeri Yvonne Jozef Sels 212,832 0.20%
    Jbwere (Nz) Nominees Limited 206,990 0.20%
    FNZ Custodians Limited i 193,348 0.18%
    MMC Queen Street Nominees Ltd Acf Salt Funds Management 189,000 0.18%
    David Mark Flacks & Adina Rita Betty Halpern 158,764 0.15%

    Profile

    since

    Note